Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 8,314 Shares of Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 8,314 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $20.10, for a total value of $167,111.40. Following the completion of the transaction, the chief operating officer owned 258,362 shares of the company’s stock, valued at $5,193,076.20. The trade was a 3.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Tuesday, August 18th, Matthew Fraser Ahearn sold 14,186 shares of Shoulder Innovations stock. The stock was sold at an average price of $20.99, for a total value of $297,764.14.
• On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.84, for a total value of $78,072.96.
• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.68, for a total value of $296,190.08.

Shoulder Innovations Stock Performance

Shares of SI stock opened at $21.09 on Wednesday. The firm has a market capitalization of $439.16 million and a price-to-earnings ratio of -10.99. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. The business’s 50-day moving average price is $20.72 and its 200-day moving average price is $16.37. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59.

Shoulder Innovations (NYSE:SI) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The firm had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. Equities research analysts forecast that Shoulder Innovations, Inc. will post -1.9 EPS for the current year.

Hedge Funds Weigh In On Shoulder Innovations

A number of hedge funds have recently bought and sold shares of the company. Sectoral Asset Management Inc. lifted its holdings in Shoulder Innovations by 14.4% in the fourth quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock valued at $7,042,000 after buying an additional 62,153 shares during the period. Deerfield Management Company L.P. acquired a new stake in Shoulder Innovations during the 3rd quarter worth about $6,056,000. Alyeska Investment Group L.P. acquired a new stake in Shoulder Innovations during the 3rd quarter worth about $5,667,000. Roubaix Capital LLC raised its position in shares of Shoulder Innovations by 61.9% in the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares in the last quarter. Finally, Vanguard Group Inc. acquired a new position in shares of Shoulder Innovations in the 3rd quarter valued at about $1,836,000.

Analyst Ratings Changes

SI has been the subject of several analyst reports. Weiss Ratings raised shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. UBS Group increased their price objective on Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, August 10th. BTIG Research lifted their target price on Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research report on Friday, August 7th. Six investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $23.50.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.